Examinant per Autoria "CETLAM Group"
Mostrant 1 - 2 de 2
Resultats per pàgina
Opcions d'ordenació
Ítem Accés Obert Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival(BioMed Central, 2021) Cabezón, Marta; Arenillas Rocha, Leonor; Zamora, Lurdes; CETLAM Group
Ítem Accés Obert Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidine(Impact Journal, 2018) Cabezón, Marta; Bargay, Joan; Xicoy, Blanca; García, Olga; Borràs, Josep M.; Tormo, Mar; Marcé, Sílvia; Pedro Olive, Carme; Valcárcel, David; Jiménez, Maria-José; Guàrdia, Ramón; Valcárcel, David; Jiménez, Maria-José; Palomo, Laura; Brunet, Salut; Vall-llovera, Ferrán; García, Antonio; Feliu, Evarist; Zamora, Lurdes; CETLAM Group